Malignant primary brain tumors are the leading cause of cancer deaths among children and young adults with few therapeutic options. Treatments are limited by the blood–brain barrier, a unique structure within the brain ...
May 9, 2024
0
0
Bile duct cancer, also known as cholangiocarcinoma, forms in the thin tubes that carry bile from your liver to your gallbladder and small intestine. Though relatively rare, cholangiocarcinoma is often diagnosed in later stages, ...
Jan 15, 2024
0
20
An average of 22 adolescents 14 to 18 years of age died in the U.S. each week in 2022 from drug overdoses, raising the death rate for this group to 5.2 per 100,000—driven by fentanyl in counterfeit pills, new research finds.
Jan 8, 2024
0
70
Immune system dysregulation and elevated inflammation contribute to the development of the fatal neurodegenerative condition amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.
Jul 11, 2024
0
51
Inflammatory bowel disease (IBD) is a complex condition that requires individualized care to meet the needs of the patient's current disease state. With available medications sometimes causing serious side effects or losing ...
May 7, 2024
0
64
The U.S. Food and Drug Administration has approved Winrevair (sotatercept-csrk) as an injectable treatment for pulmonary arterial hypertension (PAH) in adults.
Mar 29, 2024
0
1
For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.
Apr 9, 2024
0
2
About 1 in 8 U.S. adults (12%) have tried a weight-loss drug like Wegovy, Ozempic, Zepbound or Mounjaro, a new KFF Health Tracking Poll says.
May 10, 2024
0
0
When testing a new medicine, researchers must do more than assess how well that drug works. They also have to determine whether the medicine has some negative, unintended consequences.
Feb 22, 2024
0
9
Tirzepatide, a medication authorized to treat obesity and/or type 2 diabetes, consistently reduces bodyweight regardless of the patient's body mass index (BMI before treatment), from the range of overweight to class III obesity.
Mar 13, 2024
0
0
